Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.43M Buy
11,143
+2,139
+24% +$250K 0.44% 33
2026
Q1
$1.08M Sell
9,004
-74
-0.8% -$8.54K 0.36% 41
2025
Q4
$956K Sell
9,078
-38
-0.4% -$3.57K 0.32% 48
2025
Q3
$765K Sell
9,116
-37
-0.4% -$3.05K 0.27% 60
2025
Q2
$725K Buy
9,153
+707
+8% +$56.2K 0.27% 59
2025
Q1
$758K Buy
8,446
+342
+4% +$31.9K 0.3% 54
2024
Q4
$806K Buy
8,104
+36
+0.4% +$3.71K 0.33% 52
2024
Q3
$916K Sell
8,068
-670
-8% -$79.6K 0.36% 47
2024
Q2
$1.08M Sell
8,738
-66
-0.7% -$8.5K 0.44% 42
2024
Q1
$1.16M Buy
8,804
+662
+8% +$81.6K 0.48% 39
2023
Q4
$888K Buy
8,142
+3,730
+85% +$387K 0.39% 46
2023
Q3
$454K Buy
+4,412
New +$476K 0.22% 61

Other funds holding MRK

Rogco LP's MRK Position: Q2 2026 in Review

Rogco LP increased its Merck (MRK) stake by 24% in Q2 2026, buying an estimated $250K and bringing the position to 11,143 shares worth $1.43M. The position accounts for 0.44% of the portfolio, ranked #33.

Rogco LP first reported a position in MRK in Q3 2023 and has held it in 12 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Rogco LP held 11,143 shares of Merck worth $1.43M as of Q2 2026.
  • Rogco LP bought 2,139 Merck shares in Q2 2026, an estimated $250K.
  • Merck made up 0.44% of Rogco LP's portfolio in Q2 2026, its #33 holding.
  • Rogco LP first reported a position in Merck in Q3 2023 and has held it in 12 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Rogco LP's 13F filing for Q2 2026, filed 30 Jul 2026.